Search
Sellas Life Sciences Group Inc
SLSAdd to Watchlist
13.860USD
+0.160+1.17%
Close 09-04 16:00（ET）
2.80BMarket Cap
LossP/E TTM
Forecast
Currency: USD Updated: 2026-09-04The current earnings forecast score of Sellas Life Sciences Group Inc is 8.00, ranking 168 out of 368 in the Biotechnology & Medical Research industry. The average price target is 7.00, with a high of 7.50 and a low of 6.00.
Analyst Rating
Based on
2
analysts
Buy
Current Rating
32.500
Target Price
+134.49%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
497
Total
6
Median
7
Average
Company name
Ratings
Analysts
Sellas Life Sciences Group Inc
SLS
2
argenx SE
ARGX
28
Beigene Ltd
ONC
28
Ionis Pharmaceuticals Inc
IONS
26
Insmed Inc
INSM
24
IQVIA Holdings Inc
IQV
24
1
2
3
...
100
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Sellas Life Sciences Group Inc's price target?
Analysts forecast that Sellas Life Sciences Group Inc's price target is USD 7.00, with the highest forecast at USD 7.50 and the lowest forecast at USD 6.00.
How have Sellas Life Sciences Group IncSLS's recent earnings per share performed?
The market expectation was USD -0.05, while Sellas Life Sciences Group IncSLS's earnings per share (EPS) for the previous quarter was USD -0.05. EPS for the next quarter is expected at USD -0.05.
What is the analyst rating for Sellas Life Sciences Group Inc?
Based on the ratings of Sellas Life Sciences Group Inc's stock from 2 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.